D4: What’s the Best Way to Build a Pharma R&D Data Strategy?
One of the most vital aspects of drug development is the implementation of new data strategies and analytical approaches to inform better decision-making. Nowadays, pharma needs to improve the efficiency of research and clinical trials. R&D, IT and data leaders are under pressure to act quickly.
But progress in pharma is slow, in an environment that’s driven by tight deadlines. To counter this, innovation, understanding the value in change, challenging long-held beliefs, setting a clear vision or objectives and building and winning the business case are all critical.
Which is where D4: Pharma, a brand new event from Front Line Genomics, comes in.
Taking place on 20 & 21 March 2019 in Cambridge, Massachusetts, this is the first conference to specifically help pharma and biotech companies build and execute a scaleable, sustainable and future-resistant R&D data strategy, including innovative yet accessible new approaches, methods and ways of looking at the data life cycle that drive incredible value within pharma R&D.
D4: Pharma is a highly select gathering of 80-100 very senior and experienced pharma professionals responsible for making important decisions, as well as turning innovation and new ideas into measurable progress. We believe it’s the best place for focused learning, intelligence-gathering and senior-level networking.
The agenda has been carefully crafted from research conducted at eight boardroom-style meetings in London and Boston across 2018, which identified the challenges, priorities and best solutions reflected on the agenda. Further interviews were conducted to fine-tune topics and decide on the best format to address each issue.
The result is a series of senior-level presentations and case-studies (from pharma and the FDA) packed into a two-day conference and augmented with over 10+ hours of networking time, round-table discussions, panels and group sessions. No “death by PowerPoint” here. It’s packed full of engaging sessions where attendees are encouraged to be part of the discussion.
Attendees will leave armed with unrivalled intelligence, tools and solutions to take back to their company. Plus dozens of informal connections to help you lead the change process, make crucial decisions and execute on the near-term progress that is so desperately required.